Trevena, Inc. - Common Stock (TRVN)
2.5000
0.00 (0.00%)
Trevena Inc is a biopharmaceutical company that focuses on developing innovative therapies to treat various central nervous system disorders and acute pain conditions
The company leverages its proprietary drug discovery platform to create novel molecules that target specific receptors in the brain and nervous system, aiming to provide safer and more effective treatment options. By prioritizing patient safety and reducing reliance on opioids, Trevena is actively exploring advanced therapies that can improve the quality of life for patients suffering from difficult-to-treat medical conditions.
Frequently Asked Questions
Is Trevena, Inc. - Common Stock publicly traded?
Yes, Trevena, Inc. - Common Stock is publicly traded.
What exchange does Trevena, Inc. - Common Stock trade on?
Trevena, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Trevena, Inc. - Common Stock?
The ticker symbol for Trevena, Inc. - Common Stock is TRVN on the Nasdaq Stock Market
What is the current price of Trevena, Inc. - Common Stock?
The current price of Trevena, Inc. - Common Stock is 2.500
When was Trevena, Inc. - Common Stock last traded?
The last trade of Trevena, Inc. - Common Stock was at 4:00 pm EDT on October 7th, 2024
What is the market capitalization of Trevena, Inc. - Common Stock?
The market capitalization of Trevena, Inc. - Common Stock is 2.16M
How many shares of Trevena, Inc. - Common Stock are outstanding?
Trevena, Inc. - Common Stock has 863.79K shares outstanding.